HLA-DQ2 peptide vaccine (ImmusanT)

N/A

Report date: 2024/11/18 20:00:28

Base Information

Drug NameHLA-DQ2 peptide vaccine (ImmusanT)
Drug Alias NameCoeliac disease peptide vaccineNexvax2
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsAutoimmune DiseasesMetabolic DiseasesCeliac Disease +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNexpep Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNexpep Pty LtdImmusant Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesMetabolic DiseasesCeliac Disease +[7] 

Other Information

ATC CodeN/A
Related LinksN/A